T he intact blood-brain barrier (BBB) prevents passage of larger hydrophilic molecules (> 180 Da) from the systemic vasculature into the CNS parenchyma. 14, 24, 27 The intact BBB is composed of tight junctions between vascular endothelial cells and is maintained by essential interactions between tightly apposed astrocytic foot processes and the vascular endothelial cells. 1, 6, 15, 26, 35, 36 Magnetic resonance imaging contrast enhancement of cerebral metastases and malignant gliomas indicates that the BBB is compromised in certain CNS tumor types. Understanding the structural and cellular features of tumor-associated BBB disruption has implications for tumor vessel formation, potential therapeutic targets, and treatment strategies.
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Data indicate that alterations in vascular endothelial cell tight junctions partially underlie neoplasm-associated BBB disruption. 11, 19, 31, 37 Nevertheless, these changes do not explain many features of neoplastic BBB disruption, and further insight into the effects of the astrocytic contribution to the BBB in intracerebral neoplasia is needed. To gain deeper understanding into effects of the astrocytic contribution to the BBB in brain neoplasia, we systematically analyzed the vascular features of metastatic and primary brain tumors. Specifically, we examined the astrocyte-endothelial cell relationship of the BBB at sites of MRI contrast enhancement and compared it to the relationship at sites without contrast enhancement.
Methods

Patients and Tumors
Tumors were collected and analyzed under an institutional review board-approved protocol (NIH 03-N-0164). All patients provided informed consent for study participation.
Imaging Evaluation
Patients underwent high-resolution preoperative T1-weighted MRI before and after administration of a contrast agent. Lesions were classified as enhancing or nonenhancing based on the presence of hyperintensity on postcontrast T1-weighted MR images. T2-weighted sequences were used to assess for peritumoral edema, cyst formation, and tumor distribution (low-grade astrocytoma).
Tumor Specimen Collection
Resection of metastatic and primary tumors was performed with frameless stereotactic Instatrak 3000 (General Electric) or StealthStation Treon (Medtronic) guidance. Metastatic deposits were removed by en bloc resection that included removal of 2 mm of the immediately adjacent brain parenchyma surrounding the lesion. Low-grade gliomas were also removed by en bloc resection; upon removal, the tumor was marked to permit histoanatomical correlation with preoperative MRI. In patients undergoing resection of high-grade gliomas, biopsy specimens were obtained from enhancing and nonenhancing regions of the tumors and recorded to permit histological correlation with preoperative MRI. The remaining portion of the tumor was then removed en bloc and marked to permit histoanatomical correlation with preoperative MRI.
Histological Analysis
Histological examination of tissues stained with H & E was performed for diagnostic purposes and to define the morphological features of the tumor vasculature throughout the lesions and associated tumor-brain interface (when present). The MIB-1 proliferation index was determined for all tumors, and glial tumors were evaluated for GFAP expression. Pathological samples were submitted with detailed descriptions, including corresponding imaging findings.
Immunohistochemical Analysis
To assess perivascular astrocytic foot processes, double immunofluorescence staining for CD31 and GFAP was performed on sections from each tumor (rabbit anti-CD31 [EP3095, Millipore; 1:200] and mouse anti-GFAP [G3893, Sigma-Aldrich; 1:200]). We also evaluated astrocytic foot processes using AQ4, which is preferentially located within the basement membrane of these astrocytic processes. Double immunofluorescence staining for CD31 and AQ4 was performed on each tumor (mouse anti-CD31 [M0823, Dako; 1:200] and rabbit anti-AQ4 [AB2218, Millipore 1:200]). Secondary goat anti-rabbit IgG antibody absorbing at a wavelength of 594 nm (A21207, Invitrogen; 1:200) and goat anti-mouse IgG antibody at a wavelength of 488 nm (A21202, Invitrogen; 1:200) were applied to tissue samples. Vectashield HardSet mounting medium with 4ʹ, 6-diamidino-2-phenylindole (DAPI) (Vector Laboratories) was used to create blue immunofluorescence at an excitation wavelength of 360 nm at sites containing DNA. Immunofluorescent images were captured using a Leica LSM 510 confocal microscope, while bright-field microscope images were captured using a Leica DM LB microscope with a Spot Imaging camera and software.
Results
Patient Characteristics
Twelve patients harboring 12 metastatic deposits or gliomas were included in the study (3 women, 9 men). Their mean age was 49.9 ± 15.8 years (range 23-74 years). A summary of their demographic and clinical characteristics is provided in Table 1 .
Imaging Characteristics
Metastases. All metastatic deposits enhanced vividly and homogeneously on postcontrast T1-weighted MR images (Fig. 1) . Metastatic deposits were found in the parietal, frontoparietal, and temporal lobes of the brain at the gray-white junction ( Table 2 ). T2-weighted MRI demonstrated peritumoral edema that uniformly surrounded the deposits and extended into the immediately surrounding white matter.
Low-Grade Gliomas. In each of the 2 patients with low-grade gliomas, the lesion was in the frontal lobe and was identified as a hypointense area on T1-weighted MRI that corresponded to a T2 hyperintensity in the same region ( Fig. 2 ). There was no significant peritumoral edema and there was minimal mass effect on the immediately surrounding tissues. There was lack of contrast-enhancement on T1-weighted MRI in both cases of low-grade glioma.
Malignant Gliomas (Anaplastic Astrocytoma and Glioblastoma Multiforme).
All malignant gliomas demonstrated irregular enhancement on T1-weighted MRI except for 1 anaplastic astrocytoma that did not demonstrate evidence of contrast enhancement. Associated cerebral edema emanated from the tumors into the surrounding white matter and was associated with corresponding mass effect (Figs. 3-5).
Tumor Characteristics
Metastases. Metastatic deposits were histologically discrete lesions that demonstrated morphology consistent with the known primary tumor. A thin rim of GFAPpositive parenchyma surrounded the lesions. There was a distinct border between the neoplastic tissue and the surrounding brain ( Fig. 1 ) that made analysis of the vasculature at the metastasis-brain interface possible.
Low-Grade Gliomas. Low-grade gliomas demonstrated increased cellularity within the cerebral white matter, consisting of GFAP-positive neoplastic cells. The neoplastic cells demonstrated evidence of cellular atypia. There was lack of increased mitotic activity, vascular proliferation, or pseudopalisading necrosis (Fig. 2) .
Malignant Gliomas. Anaplastic astrocytomas demonstrated GFAP-positive cells, prominent mitoses, increased cellularity, and mitoses without vascular proliferation or necrosis. Glioblastoma multiforme specimens demonstrated GFAP-positive cells, prominent mitoses, increased cellularity, and mitoses with pseudopalisading necrosis (Figs. 3 and 5) .
Correlation of Imaging and Astrocyte-Endothelial Cell Relationship
Metastases. Within metastatic deposits and consistent with disruption of the astrocytic component of the BBB, there was absence of GFAP or AQ4 immunoreactivity adjacent to CD31-positive vessels (Fig. 1) . CD31-positive endothelial cells within the tumor mass were thin and dysmorphic (compared with normal parenchyma endothelial cells). Glial processes were absent within the metastases. The physiological astrocyte-endothelial cell relationship of the BBB was reconstituted at the tumor-brain interface surrounding metastases as demonstrated by tight orientation of the astrocytic foot processes and uniform AQ4 staining along the luminal side of the glial process surrounding each vessel.
Low-Grade Astrocytomas. The histological morphology of the intratumoral vasculature in low-grade gliomas was normal (Fig. 2) . Vessels within the tumor tissues in low-grade astrocytomas were associated with tight circumferential orientation of GFAP-positive glial processes around the vasculature (Fig. 2) . AQ4 staining was particularly intense and uniform along the luminal side of the glial processes surrounding each vessel. There was AQ4 and GFAP staining in the glioma cells, but these cells were relatively small in number as compared with the normal cells with typical glial processes.
High-Grade Gliomas. Consistent with breakdown of the astrocytic contribution to the BBB, gaps in GFAP or AQ4 immunoreactivity surrounding the vessels (Figs. 3,  4 , and 5) in enhancing portions of high-grade gliomas were found. Diffuse GFAP and AQ4 staining was seen throughout enhancing lesions, showing disorganized glial staining that was associated with glioma cells. These cells did not have the normal elongated processes expected of typical glial cells, but rather were discrete, atypical cells without organized glial processes. There was an absence of immunofluorescence of GFAP or AQ4 surrounding the vasculature of these lesions. Nonenhancing regions were associated with return of the tight orientation of the glial processes, and uniform AQ4 staining was found along the luminal side of the glial process surrounding the CD31-positive vasculature.
Discussion
Previous Studies
The normal BBB in brain has been well characterized and includes tight junctions between vascular endothelial cells as well as essential interactions between immediately surrounding astrocyte processes and endothelial cells. 1, 6, 28 Previous studies have examined histological and immunohistochemical features of tight junctions associated with vascular endothelial cells of metastatic and primary tumors. Alterations in claudin expression at tight junctions have been demonstrated in tumors, as well as inflammatory disorders of the nervous system, 19, 31, 37 suggesting that the tight junctions are disrupted and are associated, at least in part, with BBB breakdown in a variety of CNS pathological states, including neoplasia.
While changes in tight junction morphology and function have been implicated with BBB breakdown in tumor vasculature, the potential changes associated with the astrocytic component of the BBB have not been defined. Better understanding of astrocyte-endothelial cell interactions in the BBB of brain tumors can provide insight into mechanisms linked with neoplasia-associated BBB breakdown and tumor vascular development and may present opportunities for targeted treatment of tumor vasculature. Moreover, better understanding of the astrocyte-endothelial cell relationship in disease states can provide critical understanding to improve therapy in conditions associated with BBB breakdown. Here, we characterized the astrocytic contribution to the BBB in brain tumors.
Current Study
Analysis. To best evaluate the integrity of the astrocytic component of the BBB in a variety of neoplastic states, we performed immunohistochemical analysis on metastatic and primary (low-and high-grade glioma) brain tumors. CD31, or platelet endothelial cell adhesion molecule, is a well-established and well-characterized marker of vessels. 2 To define astrocyte interactions on tumor vessels, we used GFAP (intracellular glial filaments) 28 to demonstrate astrocytic distribution and morphology. Aquaporin 4 immunohistochemistry was used to demonstrate the integrity (or lack thereof) of glial basement membrane surrounding blood vessels. 34 For comparison purposes, the intact BBB demonstrates CD31-positive vessels tightly surrounded by GFAP-positive glial processes with AQ4 staining lining the luminal side of the glial processes, consistent with a phenotypically normal basement membrane. 9 Metastases. Breakdown of the BBB in metastatic deposits is clearly demonstrated by discrete uniform intralesional gadolinium-based contrast enhancement on MRI. Consistent with these imaging findings, previous studies have indicated that endothelial cell tight junctions within brain metastases are abnormal and disrupted. 10 Further, the current study demonstrates that the astrocytic contribution to the BBB throughout the metastatic deposits is also disrupted. Consequently, BBB barrier disruption in metastatic deposits appears to be the result of both tight junction dysfunction and breakdown of normal astrocyte-endothelial cell interaction. Alternatively, near the periphery of the metastatic deposits (the metastasis-brain interface), vessels reconstituted a normal astrocyte-endothelial cell relationship with tight association of the glial processes surrounding vessels.
Glioma. Low-grade gliomas demonstrated a tight arrangement of astrocytic processes and intact astrocytic basement membrane surrounding intratumoral vessels that is consistent with an intact astrocytic component of the BBB. Based on the normal appearance of intratumoral vessels in these tumors, it does not appear that significant angiogenesis occurs in these lesions. Consistent with known glioma cell biology it seems plausible that neoplastic cells invade normal brain and receive nutrients by diffusion from existing phenotypically normal astrocyteendothelial cell interactions. 7 Although there is increased neoplastic cellularity in these lesions, unaffected astrocytes formed tight processes that surround vessels and a basement membrane that produced a phenotypically normal BBB. The presence of a normal astrocyte-endothelial cell relationship within these nonenhancing tumors was consistent with MRI evidence of an intact BBB.
Consistent with breakdown of the BBB in high-grade gliomas, MRI enhancement was found in portions of these lesions. Regions of MRI enhancement in high-grade gliomas demonstrated loss of the normal tight astrocytic fibrillary arrangement of glial processes and associated basement membrane surrounding the intratumoral vasculature.
There was diffuse GFAP and AQ4 staining throughout the tumor but a lack of the normal uniform GFAP and AQ4 staining pattern association with an intact BBB. Specifically, there were gaps in GFAP and AQ4 staining between vessels and surrounding glial processes consistent with breakdown of the astrocytic component of the BBB. The immunohistochemistry-imaging correlation revealed a consistent association between BBB breakdown demonstrated by contrast-enhanced MRI and disruption of the astrocyte-endothelial cell relationship.
Clinical Implications
The data from the current study can provide insight into BBB breakdown and peritumoral edema formation. Specifically, the breakdown of the BBB in metastases and high-grade gliomas is associated with disruption of endothelial tight junctions. Extravasation of plasma ultrafiltrate through leaky endothelial vessels underlies peri- tumoral edema formation. [20] [21] [22] Dexamethasone reduces BBB permeability at endothelial tight junctions and can reduce peritumoral edema. 8, 12, 16, 18 These steroid effects on the BBB appear to replicate the properties of the perivascular astrocytes in the brain.
3,4,29,33
Conclusions
It is critical to understand the impact of nervous system neoplasia on the BBB. Not only do the current findings provide insight into the effect of BBB breakdown on peritumoral edema, but they also provide a deeper understanding of tumor development, progression, and treatment. 25 Specifically, understanding the alterations in the astrocyte relationship to the vascular endothelial cells in the BBB permits deeper comprehension of mechanisms associated with metastasis development, 17 chemoresistance in metastatic and primary tumors, 13 ,32 mechanisms to improve drug delivery, 5, 23 and immune cell trafficking in neoplasia. 
